Literature DB >> 22283227

Effect of lidocaine gel anesthesia on endophthalmitis rates following intravitreal injection.

Eleonora M Lad1, Mitchell G Maltenfort, Theodore Leng.   

Abstract

BACKGROUND AND
OBJECTIVE: To determine whether the use of lidocaine gel before application of povidone-iodine affects endophthalmitis rates following intravitreal injections. PATIENTS AND METHODS: Retrospective consecutive case series of all intravitreal injections and post-intravitreal injection endophthalmitis cases at one institution from 2000 to 2009. A review of medical records of post-intravitreal injection endophthalmitis cases was performed to determine whether lidocaine gel was applied prior to povidone-iodine antisepsis and to analyze the clinical course and outcomes.
RESULTS: A total of 8,802 intravitreal injections were administered during the study period. When no lidocaine gel was used prior to povidone-iodine antisepsis, four cases of endophthalmitis following 4,120 intravitreal injections (0.097%) were recorded. When 2% lidocaine gel was applied before povidone-iodine, four cases of endophthalmitis following 4,682 intravitreal injections (0.085%) were observed (P = 1.00, odds ratio = 1.12).
CONCLUSION: The use of lidocaine gel prior to povidone-iodine antisepsis did not significantly alter post-intravitreal injection endophthalmitis rates. Copyright 2012, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22283227     DOI: 10.3928/15428877-20120119-01

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  9 in total

1.  Predictors of Endophthalmitis after Intravitreal Injection: A Multivariable Analysis Based on Injection Protocol and Povidone Iodine Strength.

Authors:  Maxwell S Stem; Prethy Rao; Ivan J Lee; Maria A Woodward; Lisa J Faia; Jeremy D Wolfe; Antonio Capone; Douglas Covert; A Bawa Dass; Kimberly A Drenser; Bruce R Garretson; Tarek S Hassan; Alan Margherio; Kean T Oh; Paul V Raephaelian; Sandeep Randhawa; Scott Sneed; Michael T Trese; Sunita Yedavally; George A Williams; Alan J Ruby
Journal:  Ophthalmol Retina       Date:  2018-09-25

2.  Novel Combined Lidocaine/Povidone Iodine Delivery System for Preintravitreal Injection.

Authors:  Parissa Ziaei; Jayde L Resnick; Nicholas Stella; Morgan V DiLeo
Journal:  J Ocul Pharmacol Ther       Date:  2022-03-07       Impact factor: 2.850

3.  Minimizing the endophthalmitis rate following intravitreal injections using 0.25% povidone-iodine irrigation and surgical mask.

Authors:  Hiroyuki Shimada; Takayuki Hattori; Ryusaburo Mori; Hiroyuki Nakashizuka; Kyoko Fujita; Mitsuko Yuzawa
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-02-07       Impact factor: 3.117

4.  Endophthalmitis Associated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections.

Authors:  Stephen G Schwartz; Harry W Flynn
Journal:  Curr Ophthalmol Rep       Date:  2014-03-01

Review 5.  Endophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injection: a comprehensive review.

Authors:  Rohan Merani; Alex P Hunyor
Journal:  Int J Retina Vitreous       Date:  2015-07-21

Review 6.  Current Evidence for the Prevention of Endophthalmitis in Anti-VEGF Intravitreal Injections.

Authors:  P Et Lau; K S Jenkins; C J Layton
Journal:  J Ophthalmol       Date:  2018-07-24       Impact factor: 1.909

Review 7.  Anesthesia for Intravitreal Injection: A Systematic Review.

Authors:  Jonathan Han; Nicholas T Rinella; Daniel L Chao
Journal:  Clin Ophthalmol       Date:  2020-02-26

8.  Causative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents.

Authors:  Cecilia P Labardini; Eytan Z Blumenthal
Journal:  Rambam Maimonides Med J       Date:  2018-09-02

Review 9.  Preventive factors, diagnosis, and management of injection-related endophthalmitis: a literature review.

Authors:  Rupali Singh; Samaneh Davoudi; Steven Ness
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-03-12       Impact factor: 3.535

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.